Showing results (1271-1280 of 2,826) with videos related to

Sort By:
Pageof 283
Journal of Clinical Gastroenterology|December 1, 1995
Monophasic luminal release of prostaglandin E2 in patients with reflux esophagitis under the impact of acid and acid/pepsin solutions. Its potential pathogenetic significanceM Marcinkiewicz, J Sarosiek, M Edmunds, et al.
BMC Medical Education|September 13, 2015
Scholarly research productivity is not related to higher three-year licensure pass rates for physical therapy academic programsChad E Cook, Michel D Landry, Jeffrey Kyle Covington, et al.
Bioengineering (Basel, Switzerland)|February 8, 2018
Delivery of Mesenchymal Stem Cells from Gelatin-Alginate Hydrogels to Stomach Lumen for Treatment of GastroparesisBinata Joddar, Nishat Tasnim, Vikram Thakur, et al.
Physics in Medicine and Biology|November 26, 2020
Evaluating the image quality of combined positron emission tomography-magnetic resonance images acquired in the pelvic radiotherapy positionJonathan J Wyatt, Elizabeth Howell, Maelene Lohezic, et al.
ACG Case Reports Journal|October 10, 2022
Virtual Reality and Mindfulness Approaches in the Treatment of Rumination SyndromeJeff Angelo Taclob, M Ammar Kalas, Marcus Juan Esteban, et al.
The American Journal of Medicine|June 28, 2019
Relation of Kidney Function Decline and NT-proBNP With Risk of Mortality and Readmission in Acute Decompensated Heart FailureWendy McCallum, Hocine Tighiouart, Michael S Kiernan, et al.
International Journal of Genomics|August 18, 2020
Genome-Wide Association Study towards Genomic Predictive Power for High Production and Quality of Milk in American Alpine GoatsY Tilahun, T A Gipson, T Alexander, et al.
Alimentary Pharmacology & Therapeutics|August 6, 1998
Effect of octreotide on gastric and small bowel motility in patients with gastroparesisM C Edmunds, J D Chen, I Soykan, et al.
Physics in Medicine and Biology|August 14, 1998
Recent developments in combining LODESR imaging with proton NMR imagingI Nicholson, F J Robb, S J McCallum, et al.
Investigational New Drugs|August 25, 2012
Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neckTanguy Seiwert, John Sarantopoulos, Howard Kallender, et al.
Pageof 283